BCRX
BIOCRYST PHARMACEUTICALS INC
BIOCRYST PHARMACEUTICALS INC (BCRX) has 17 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 15, 2026.
Insiders have net sold $697K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Charles K. Gayer
- Employees:435
- HQ:Durham, NC, US
- IPO:1994-03-04
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$697K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$2.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
McKee Amy EFirst filing | Director | Sale | 11,180 | $100K | May 19 | SEC ↗ |
Barnes Alane PFirst filing | Chief Legal Officer | Sale | 62,500 | $596K | May 15 | SEC ↗ |
Related companies
BIOCRYST PHARMACEUTICALS INC is in the Healthcare sector.